__timestamp | ADMA Biologics, Inc. | Amgen Inc. |
---|---|---|
Wednesday, January 1, 2014 | 3742367 | 4422000000 |
Thursday, January 1, 2015 | 4311461 | 4227000000 |
Friday, January 1, 2016 | 6360761 | 4162000000 |
Sunday, January 1, 2017 | 29164321 | 4069000000 |
Monday, January 1, 2018 | 42194635 | 4101000000 |
Tuesday, January 1, 2019 | 39504238 | 4356000000 |
Wednesday, January 1, 2020 | 61291426 | 6159000000 |
Friday, January 1, 2021 | 79769341 | 6454000000 |
Saturday, January 1, 2022 | 118814535 | 6406000000 |
Sunday, January 1, 2023 | 169273000 | 8415000000 |
Monday, January 1, 2024 | 12858000000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, understanding cost structures is crucial. This analysis delves into the cost of revenue for two industry players: Amgen Inc. and ADMA Biologics, Inc., from 2014 to 2023. Over this period, Amgen's cost of revenue consistently dwarfed that of ADMA, reflecting its larger scale and market presence. In 2023, Amgen's expenses surged to 8.4 billion, marking a 90% increase from 2014. Meanwhile, ADMA's costs grew exponentially, rising by over 4,400% to reach 169 million in 2023. This stark contrast highlights the differing growth trajectories and operational scales of these companies. While Amgen's costs reflect its established market dominance, ADMA's rapid increase underscores its aggressive expansion strategy. These insights provide a window into the financial dynamics shaping the biotech sector.
AbbVie Inc. vs Amgen Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Amgen Inc. vs Insmed Incorporated
Cost Insights: Breaking Down Amgen Inc. and Incyte Corporation's Expenses
Analyzing Cost of Revenue: Amgen Inc. and Wave Life Sciences Ltd.
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Amgen Inc. and MiMedx Group, Inc.
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and ADMA Biologics, Inc.
Cost Insights: Breaking Down Bio-Techne Corporation and ADMA Biologics, Inc.'s Expenses
Catalent, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: ADMA Biologics, Inc. vs Geron Corporation
Cost of Revenue Comparison: ADMA Biologics, Inc. vs Mesoblast Limited